#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neovascular age-related macular degeneration Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Intracranial germ cell tumour Oropharyngeal squamous cell carcinoma Extra-osseous Ewing's sarcoma recurrent Toxic epidermal necrolysis Neuroendocrine carcinoma metastatic Pulmonary alveolar haemorrhage Friedreich's ataxia Alport's syndrome Ischaemic stroke Biliary cancer metastatic Retinoblastoma Adrenogenital syndrome Infantile apnoea More trials…

    Learn about Rare Diseases

    Osteosarcoma – Treatment Piriformis syndrome – Life with Disease Pemphigus Methylmalonic acidaemia – Life with Disease Alveolar rhabdomyosarcoma – Basic Information Cystic fibrosis Angiosarcoma non-metastatic – Trials in Disease Congenital hypotransferrinaemia – Diagnostics Hepatoblastoma – Basic Information Haemophilia A without inhibitors – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dordaviprone GSKVX000000034795 Floxuridine Phleum Pratense (225) Hct116-B Alanine TRV045 Valganciclovir Epirubicin Lucerastat Dostarlimab Imatinib Mesilate Ds-3939A DUVELISIB Skin Autograft Satralizumab Mianserin Hydrochloride Azacitidine Sym025 Perflutren More therapies…

    Learn about Your Condition

    Mucosal inflammation Acute kidney injury Arterial stiffness Notalgia paraesthetica Glaucoma Procedural hypotension Optic glioma Malignant oligodendroglioma Hypertonic bladder Emphysema Otitis media Angiosarcoma non-metastatic Eye disorder Acute hepatic failure Thermal burn More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Arensia Clinics S.R.L.

Arensia Clinics S.R.L.

Intrarea Tudor Stefan 38-40, Bucharest, 011658, Romania

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ocrelizumab
    Belgium Bulgaria Croatia Czechia Denmark France +9

  • Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion

    Not recruiting

    2 1
    Investigated Diseases:
    • Cutaneous lupus erythematosus
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Enpatoran
    Bulgaria Greece Poland Romania Spain

  • Testing IDOR-1117-2520 for Adults with Moderate to Severe Chronic Plaque Psoriasis With or Without Psoriatic Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • IDOR-1117-2520C
    Bulgaria Romania

  • Study on the Effects of Lunsekimig (SAR443765) in Adults with High-Risk Asthma Not Eligible for Biologic Treatment

    Not recruiting

    2 1
    Investigated Drugs:
    • LUNSEKIMIG
    Belgium Denmark France Germany Hungary Italy +4

  • Study on How REGN9933 and REGN7508 Help Prevent Blood Clots in Adults with a Peripherally Inserted Central Catheter (PICC)

    Not recruiting

    2 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Human Igg4 S228P Monoclonal Antibody Against Factor Xi And Activated Factor Xi
    • Regn9933
    Bulgaria Romania Spain

  • Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Atuliflapon
    • Salbutamol
    Bulgaria Croatia Germany Hungary The Netherlands Poland +4

  • Study Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Cetirizine Dihydrochloride
    • Methylprednisolone
    • Ocrelizumab
    Bulgaria Croatia Czechia Poland Romania Spain

  • Study on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Eclitasertib
    Bulgaria Czechia France Germany Hungary Italy +5
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!